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Abstract
The genetic architecture of common epilepsies is largely unknown. HCNs are excellent epilepsy
candidate genes because of their fundamental neurophysiological roles. Screening in subjects with
febrile seizures and genetic epilepsy with febrile seizures plus revealed that 2.4% carried a
common triple proline deletion (delPPP) in HCN2 that was seen in only 0.2% of blood bank
controls. Currents generated by mutant HCN2 channels were ~35% larger than those of controls;
an effect revealed using automated electrophysiology and an appropriately powered sample size.
This is the first association of HCN2 and familial epilepsy, demonstrating gain of function of
HCN2 current as a potential contributor to polygenic epilepsy.
Febrile seizures (FS) and idiopathic generalized epilepsy (IGE), including genetic epilepsy
with febrile seizures plus (GEFS+), are common epilepsy syndromes that show complex
inheritance, where a combination of susceptibility variants is proposed to underlie the
etiology in most cases.1-3 A small number of susceptibility genes for IGE have been
identified and predominantly include ion channel genes.4
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Hyperpolarization-activated cyclic nucleotide-gated ion channels (HCN) conduct Ih
important for neuronal pacemaker function. There is growing evidence for a role of HCN in
both idiopathic5,6 and acquired epilepsy.7-11 HCN1 and HCN2 variants have been identified,
but functional analyses have failed to determine a statistical difference in channel
properties.12 The functional changes associated with gene variants that contribute to
polygenic disease are, by definition, subtle. Both biological and experimental variability
contribute to the variance seen in functional analyses, with the probability of failing to detect
a real difference in 2 populations rising dramatically as variation increases. To separate such
populations, the sample size needs to increase.13 Here, we used a candidate gene approach
to search for HCN1 and HCN2 variants in epilepsy subjects and a medium-throughput
automated electrophysiological assay to test channel function with appropriate sample sizes.
Currents generated by mutant HCN2 channels were ~35% larger than controls, an increase
that could enhance neuronal excitability.8,9
Subjects and Methods
Patient Collection
Diagnostic criteria for IGE and FS followed that of the Commission on Classification and
Terminology of the International League Against Epilepsy,14 and for GEFS+ followed that
of Scheffer and Berkovic.3 Patients were Australian subjects of Caucasian origin and were
screened for variants in a randomized fashion where clinical characteristics were blinded.
Controls were randomly drawn anonymous Australian blood donors primarily of Caucasian
origin.
DNA Preparation and Mutation Analysis
DNA was extracted from peripheral blood using the QIAamp DNA Blood Maxi Kit
(Qiagen, Valencia, Germany). Hexosaminidase-labeled intronic primers flanking each exon
were used to polymerase chain reaction (PCR)-amplify products between 250bp to 320bp,
and the products were analyzed by single-strand conformation analysis (SSCA) on a real-
time gel system using a Gel-Scan 2000 DNA fragment analyzer (Corbett Research,
Mortlake, Australia). Products showing band shifts were sequenced using the BigDye
Terminator Cycle Sequencing Ready Reaction kit (PE Applied Biosystems, Foster City, CA,
v2.0), and the sequences were analyzed on an Applied Biosystems ABI Prism 3700 DNA
Analyzer.
The HCN1 open reading frame (accession number NM_021072) contains 8 exons, which
were divided into 13 amplicons for SSCA. The human HCN2 open reading frame (accession
number NM_001194) contains 8 exons, which were divided into 14 amplicons for SSCA.
We used single nucleotide polymorphisms (SNPs) to distinguish the genomic sequence
spanning the HCN2 gene on chromosome 19 from the highly related chromosome 15
sequence. HCN1 is located on chromosome 5. Primer sequences used for PCR and SSCA
can be found in Supporting Information.
HCN Mutagenesis and In Vitro Transcription
See Supporting Information.
HCN 2-Electrode Voltage Clamp Analysis and Statistical Design
Oocytes from Xenopus laevis were prepared as previously described.15 Thirty-five
nanoliters of cRNA-encoding the wild-type (WT) and delPPPHCN2 subunits (65ng/μl; stocks
confirmed spectrophotometrically and by gel analysis) was injected into stage 5/6 oocytes
using the Roboocyte (Multi Channel Systems, Reutlingen, Germany) and stored for 2 days
prior to experimentation. For voltage clamp recordings, oocytes were impaled with 2 glass
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electrodes containing 1.5M potassium acetate (I) and 0.5M KCl (V) and clamped at a
holding potential of −30mV. A current-voltage (I-V) relationship was generated by
incrementing voltage in 10mV steps from −140mV to 0mV for 15 seconds with a 2-second
test potential of −140mV at the end of the pulse. Oocytes were perfused with a bath solution
(mM): 96 KCl, 2 NaCl, 2 MgCl2, and 10 HEPES (pH 7.5 using KOH). To obtain
normalized I-V relationships, peak tail current amplitudes were recorded at −140mV and
were divided by the largest peak tail current. This normalized current was plotted against
voltage and fit with a Boltzmann curve (GraphPad Prism, GraphPad Software, La Jolla, CA
[average fits] and AxoGraph X, AxoGraph Scientific, Sydney, Australia [individual fits).
Cyclic adenosine monophosphate (cAMP) modulation was investigated by incubating
oocytes in 15μM forskolin (Sigma, Castle Hill, Australia) for a period of 7 minutes. Kinetics
of activation was determined by measuring the time to half maximal current using a custom
analysis program run in MatLab. Power analysis was performed using the G* Power
calculator (www.psycho.uni-duesseldorf.de/aap/projects/gpower). Statistical comparisons
were made using an unpaired t test (GraphPad Prism).
Results
Variation of HCN1 and HCN2 in Epilepsy Patients
No major-effect sequence variation was detected in human HCN1 (Table 1). Analysis of
HCN2 revealed a number of synonymous SNPs (Table 1) and a variant, c.
2156-2164delCGCCGCCGC, p.719-721PPP, predicted to lead to the deletion of 3
consecutive proline residues (delPPP) in the HCN2 protein. delPPP was found to be
heterozygous in 3/65 unrelated patients (allele frequency = 2.3%) with GEFS+ (OMIM
#604233), 3/61 unrelated patients (allele frequency = 2.5%) with FS, 3/772 blood bank
controls (allele frequency = 0.2%), and 0/72 patients with classical IGE. The 3 FS patients
had simple FS with a mean onset of 2 years. Frequency varied in each case, with 1, 3, or
multiple events. The 3 GEFS+ patients had myoclonic-astatic epilepsy, FS+ or FS (this
patient also carried the SCN1B[C121W] mutation16). Clinical characteristics of patients
who were negative for delPPP are described in Supporting Information.
Functional Analysis of delPPPHCN2 Channels
For current magnitude analysis, the inherent variance meant that sample sizes of 180 per
group were required to detect differences of 25% with a power of 0.95 to reduce type 2
errors. Although all available data were used, smaller sample sizes were sufficient for all
other parameters, because current magnitude had the highest standard deviation.
To achieve these high sample sizes, a medium-throughput electrophysiological assay was
used. WT and delPPPHCN2 currents were elicited at hyperpolarizing potentials (Fig). A
significant ~35% increase in tail current was observed for the delPPPHCN2 channel
compared with WT (5.32 ± 0.29μA vs 3.89 ± 0.23μA; n = 189 and 181, p = 0.001). Western
blot analysis showed that the total level of WT and delPPPHCN2 channel expression were the
same (Supporting Information). Normalized current-voltage relationships were also
constructed from tail currents. Half maximal activation voltage (V1/2), calculated by fitting a
Boltzmann equation to individual activation curves, was identical in the WT
and delPPPHCN2 channels (−69.9 ± 0.4mV vs −70.4 ± 0.4mV; p = 0.4). However, the slopes
of the Boltzmann curve were significantly different for WT and delPPPHCN2 channels (4.70
± 0.07 vs 5.18 ± 0.11, p = 0.0003). Activation kinetics were not significantly different across
a range of activating voltages (p > 0.35).
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cAMP Gating in delPPPHCN2 Channels
Because the delPPP variant is close to the cyclic nucleotide-binding domain, we investigated
whether cAMP gating was altered by comparing channel sensitivity to forskolin, an activator
of adenylate cyclase. V1/2 standard deviation was approximately 11% of the mean, with
power calculation suggesting that a minimum 10% difference could be detected at power
0.95 with a sample size of 50 per group. This sampling regime would be sensitive to a
minimum 2.5% change in slope factor. There was no difference in V1/2 in forskolin for the
WT and delPPPHCN2 channels (−64.2 ± 1.1mV vs −64.4 ± 1.0mV, n = 40 and 55, p = 0.6,
see Fig 1F). The slopes of the activation curve in forskolin were also not significantly
different (4.05 ± 0.08 vs 4.23 ± 0.13, p = 0.28).
Discussion
Our comparison of HCN1 and HCN2 variation in epilepsy patients and controls revealed
little genetic heterogeneity overall, suggesting an intolerance of sequence changes.
However, a deletion of 3 consecutive prolines (delPPP) in HCN2 was identified in patients
with GEFS+ and FS. The delPPP occurs in a 7-proline repeat in humans and is conserved as
a 6–7 repeat in cows, chimpanzees, dogs, and mice, suggesting functional importance. The
occurrence of the delPPP allele in controls is not unexpected, because susceptibility alleles
are predicted to be present at low frequency in the general population.2 We were able to
detect the difference in the current between WT and delPPP channels by taking advantage of
an automated electrophysiology system to record large numbers of oocytes. This enabled
statistical detection of a current magnitude increase for the mutant channel. The need for
large sample sizes is likely to become more common as an ever-increasing number of
putative susceptibility alleles are identified.
The HCN2 delPPP variant occurs with highest frequency in patients with GEFS+ and FS,
which both have febrile seizures at presentation. Increases in Ih occur following induced
febrile seizures in animal models and are proposed to contribute to hippocampal
hyperexcitability.8,9 As we did not observe HCN2 delPPP in patients with IGE, which do
not present with FS, this suggests that the variant may be a specific susceptibility allele for
FS. The impact of changes in HCN function on neuronal excitability is multifaceted, with Ih
contributing to both resting membrane potential and input resistance.17 Increases in Ih, as
predicted here, will depolarize membrane potential, taking the neuron closer to the firing
potential, and in this way be considered proexcitatory. A recent study that included
computer simulation modeling supports this view.9 It is important to note that reduced HCN
channel function is also thought to increase neuronal network excitability.5,6 Our kinetic
analysis also isolated a very subtle difference in the slope of activation of the delPPPHCN2
channel in comparison to WT, the functional significance of which is unclear.
Simple expression systems lack sufficient complexity to reveal changes that may be neuron
specific (eg, subcellular expression). Further, investigations of changes inchaperone protein
interactions (eg, TRIP8b18) and a host of other second messengers known to alter HCN
function (eg, p38 mitogen-activated protein kinase19) need to be considered. Ultimately, in
vivo modeling that allows replication of true complex genetics with the introduction of
multiple susceptibility alleles will determine the behavioral impact of the HCN2 delPPP
variant.20
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
Dibbens et al. Page 4
Ann Neurol. Author manuscript; available in PMC 2012 June 26.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Acknowledgments
This study was supported by the National Health and Medical Research Council of Australia (grants 400121 and
454655 to C.A.R. and S.P.) and an R. D. Wright Fellowship, University of Melbourne (C.A.R.).
We thank Dr N. Poolos for helpful discussions; K. S. Tan, C. Trager, and N. Taylor for technical assistance; and the
patients and their families for participating in this study. Human HCN2 cDNA was kindly provided by Dr M. Biel.
References
1. Baulac S, Gourfinkel-An I, Nabbout R, et al. Fever, genes, and epilepsy. Lancet Neurol. 2004;
3:421–430. [PubMed: 15207799]
2. Dibbens LM, Heron SE, Mulley JC. A polygenic heterogeneity model for common epilepsies with
complex genetics. Genes Brain Behav. 2007; 6:593–597. [PubMed: 17559416]
3. Scheffer IE, Berkovic SF. Generalized epilepsy with febrile seizures plus. A genetic disorder with
heterogeneous clinical phenotypes. Brain. 1997; 120(pt 3):479–490. [PubMed: 9126059]
4. Reid CA, Berkovic SF, Petrou S. Mechanisms of human inherited epilepsies. Prog Neurobiol. 2009;
87:41–57. [PubMed: 18952142]
5. Ludwig A, Budde T, Stieber J, et al. Absence epilepsy and sinus dysrhythmia in mice lacking the
pacemaker channel HCN2. EMBO J. 2003; 22:216–224. [PubMed: 12514127]
6. Strauss U, Kole MH, Brauer AU, et al. An impaired neocortical Ih is associated with enhanced
excitability and absence epilepsy. Eur J Neurosci. 2004; 19:3048–3058. [PubMed: 15182313]
7. Brewster A, Bender RA, Chen Y, et al. Developmental febrile seizures modulate hippocampal gene
expression of hyperpolarization-activated channels in an isoform- and cell-specific manner. J
Neurosci. 2002; 22:4591–4599. [PubMed: 12040066]
8. Chen K, Aradi I, Thon N, et al. Persistently modified h-channels after complex febrile seizures
convert the seizure-induced enhancement of inhibition to hyperexcitability. Nat Med. 2001; 7:331–
337. [PubMed: 11231632]
9. Bender RA, Soleymani SV, Brewster AL, Nguyen ST, Beck H, Mathern GW, Baram TZ. Enhanced
expression of a specific hyperpolarizatioin-activated cyclic nucleotide-gated cation channel (HCN)
in surviving dentate gyrus granule cells of human and experimental epileptic hippocampus. J
Neurosci. 2003; 17:6826–6836. [PubMed: 12890777]
10. Jung S, Jones TD, Lugo JN Jr, et al. Progressive dendritic HCN channelopathy during
epileptogenesis in the rat pilocarpine model of epilepsy. J Neurosci. 2007; 27:13012–13021.
[PubMed: 18032674]
11. Powell KL, Ng C, O’Brien TJ, et al. Decreases in HCN mRNA expression in the hippocampus
after kindling and status epilepticus in adult rats. Epilepsia. 2008; 49:1686–1695. [PubMed:
18397293]
12. Tang B, Sander T, Craven KB, et al. Mutation analysis of the hyperpolarization-activated cyclic
nucleotide-gated channels HCN1 and HCN2 in idiopathic generalized epilepsy. Neurobiol Dis.
2008; 29:59–70. [PubMed: 17931874]
13. Thomas EA, Reid CA, Berkovic SF, Petrou S. Prediction by modeling that epilepsy may be caused
by very small functional changes in ion channels. Arch Neurol. 2009; 66:1225–1232. [PubMed:
19822777]
14. Commission on Classification and Terminology of the International League Against Epilepsy.
Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia. 1989; 30:389–
399. [PubMed: 2502382]
15. Liu L, Zheng T, Morris MJ, et al. The mechanism of carbamazepine aggravation of absence
seizures. J Pharmacol Exp Ther. 2006; 319:790–798. [PubMed: 16895979]
16. Wallace RH, Wang DW, Singh R, et al. Febrile seizures and generalized epilepsy associated with a
mutation in the Na+-channel beta1 subunit gene SCN1B. Nat Genet. 1998; 19:366–370. [PubMed:
9697698]
17. Dyhrfjeld-Johnsen J, Morgan RJ, Soltesz I. Double trouble? Potential for hyperexcitability
following both channelopathic up- and downregulation of I(h) in epilepsy. Front Neurosci. 2009;
3:25–33. [PubMed: 19753094]
Dibbens et al. Page 5
Ann Neurol. Author manuscript; available in PMC 2012 June 26.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
18. Santoro B, Wainger BJ, Siegelbaum SA. Regulation of HCN channel surface expression by a novel
C-terminal protein-protein interaction. J Neurosci. 2004; 24:10750–10762. [PubMed: 15564593]
19. Poolos NP, Bullis JB, Roth MK. Modulation of h-channels in hippocampal pyramidal neurons by
p38 mitogen-activated protein kinase. J Neurosci. 2006; 26:7995–8003. [PubMed: 16870744]
20. Tan HO, Reid CA, Single FN, et al. Reduced cortical inhibition in a mouse model of familial
childhood absence epilepsy. Proc Natl Acad Sci U S A. 2007; 104:17536–17541. [PubMed:
17947380]
Dibbens et al. Page 6
Ann Neurol. Author manuscript; available in PMC 2012 June 26.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
FIGURE.
Electrophysiological characterization of triple proline deletion (delPPP) HCN2 channels.
(A) Steady state (top) and tail (bottom) currents from oocytes expressing wild-type (WT)
and (B) delPPPHCN2 channels. (C) Average tail current-voltage relationship of WT
and delPPPHCN2. *p < 0.05 (D) Activation curve constructed from average normalized
current relationships constructed from tail currents fit with the Boltzmann equation. (E)
Time to half maximal activation for WT and delPPPHCN2 channels across a range of
voltages. (F) Modulation of the voltage dependence of activation of WT and delPPPHCN2
channels by forskolin (forsk), data from D replotted for comparison.
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